Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (71-80 of 271) with videos related to

Pageof 28
Sort By:
Cancer|May 16, 2007
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphomaStefano Sacchi, Samantha Pozzi, Raffaella Marcheselli, et al.
Cancer|May 29, 2024
Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validationZi-Hua Li, Min-Yue Zhang, Massimo Federico, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Hematological Oncology|August 6, 2022
Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classificationIryna Kriachok, Yana Stepanishyna, Tetiana Skrypets, et al.
European Journal of Haematology|July 22, 2006
Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patientsGiuseppe Marotta, Antonio Frassoldati, Pierluigi Zinzani, et al.
Haematologica|October 17, 2015
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana LinfomiStefano Luminari, Sara Galimberti, Annibale Versari, et al.
Breast Cancer Research and Treatment|April 25, 2012
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeatLaura Cortesi, Arcangela De Nicolo, Veronica Medici, et al.
Journal of Breast Cancer|January 16, 2016
Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control StudyRaffaella Marcheselli, Luigi Marcheselli, Laura Cortesi, et al.
Frontiers in Oncology|December 6, 2021
Obesity in Postmenopausal Breast Cancer Patients: It Is Time to Improve Actions for a Healthier Lifestyle. The Results of a Comparison Between Two Italian Regions With Different "Presumed" LifestylesLaura Cortesi, Giulia Raffaella Galli, Federica Domati, et al.
BMC Cancer|January 25, 2006
Prognosis of screen-detected breast cancers: results of a population based studyLaura Cortesi, Vincenzo E Chiuri, Silvia Ruscelli, et al.
Pageof 28

Showing results (71-80 of 271) with videos related to

Sort By:
Pageof 28
Cancer|May 16, 2007
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphomaStefano Sacchi, Samantha Pozzi, Raffaella Marcheselli, et al.
Cancer|May 29, 2024
Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validationZi-Hua Li, Min-Yue Zhang, Massimo Federico, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Hematological Oncology|August 6, 2022
Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classificationIryna Kriachok, Yana Stepanishyna, Tetiana Skrypets, et al.
European Journal of Haematology|July 22, 2006
Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patientsGiuseppe Marotta, Antonio Frassoldati, Pierluigi Zinzani, et al.
Haematologica|October 17, 2015
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana LinfomiStefano Luminari, Sara Galimberti, Annibale Versari, et al.
Breast Cancer Research and Treatment|April 25, 2012
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeatLaura Cortesi, Arcangela De Nicolo, Veronica Medici, et al.
Journal of Breast Cancer|January 16, 2016
Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control StudyRaffaella Marcheselli, Luigi Marcheselli, Laura Cortesi, et al.
Frontiers in Oncology|December 6, 2021
Obesity in Postmenopausal Breast Cancer Patients: It Is Time to Improve Actions for a Healthier Lifestyle. The Results of a Comparison Between Two Italian Regions With Different "Presumed" LifestylesLaura Cortesi, Giulia Raffaella Galli, Federica Domati, et al.
BMC Cancer|January 25, 2006
Prognosis of screen-detected breast cancers: results of a population based studyLaura Cortesi, Vincenzo E Chiuri, Silvia Ruscelli, et al.
Pageof 28